| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/28/2002 | EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 08/28/2002 | EP0897386B1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/2002 | EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists |
| 08/28/2002 | CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators |
| 08/28/2002 | CN1365973A New cycloheplene compound, its preparation method and medicine composition containing same |
| 08/28/2002 | CN1365972A Indole derivatives and its anticancer usage |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex |
| 08/27/2002 | US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt |
| 08/27/2002 | US6441190 Reacting pyridinedicarboxylic acid anhydride or phthalic anhydride compound with (r)2- amino-2,3-dimethylbutyronitrile in presence of water-free solvent, hydrolysis, treating with base; separation to obtain imidazolinone compound |
| 08/27/2002 | US6441181 Compound and process for producing β-adrenergic receptor agonist |
| 08/27/2002 | US6441180 Tetrazolyl-phenyl actamide glucokinase activators |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/27/2002 | US6441176 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 08/27/2002 | US6441175 Useful in treating various neuropsychological disorders including, schizophrenia, dementia, depression, anxiety, parkinson-like motor disorders and motion disorders |
| 08/27/2002 | US6441166 Sterically hindered amine compounds |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6441001 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
| 08/27/2002 | US6441000 Compounds useful in therapy |
| 08/27/2002 | US6440995 Quinolin-4-yl derivatives |
| 08/27/2002 | US6440989 Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/27/2002 | US6440986 Viricides |
| 08/27/2002 | US6440982 Inhibitors of cyclic guanosine monophosphate diesterases |
| 08/27/2002 | US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
| 08/27/2002 | US6440974 Antitumor agents |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440972 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 08/27/2002 | US6440969 Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands |
| 08/27/2002 | US6440965 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 08/27/2002 | US6440941 Derivatives of erythromycin, their preparation process and their use as medicaments |
| 08/27/2002 | US6440618 Imaging element containing a blocked photographically useful compound |
| 08/27/2002 | US6440440 Biocidal benzylbiphenyl derivatives |
| 08/27/2002 | CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 08/27/2002 | CA2104795C 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/22/2002 | WO2002064588A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064585A1 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064568A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064567A2 Substituted carboxamides as inhibitors of factor xa |
| 08/22/2002 | WO2002064559A2 Thrombin inhibitors |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064142A1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 08/22/2002 | WO2002064141A1 New use of iloperidone |
| 08/22/2002 | WO2002064140A1 Thrombin inhibitors |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002064080A2 Matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002042280A3 Pyrimidine derivatives |
| 08/22/2002 | WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/22/2002 | WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 08/22/2002 | WO2002032893A3 Piperidine compounds as anti-allergic |
| 08/22/2002 | WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 08/22/2002 | US20020115868 Novel process for making 5-substituted pyrazoles |
| 08/22/2002 | US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 08/22/2002 | US20020115859 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials |
| 08/22/2002 | US20020115858 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115854 Thrombin or factor Xa inhibitors |
| 08/22/2002 | US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 08/22/2002 | US20020115693 Treating a variety of central and peripheral disorders; useful as positive controls in assays for BK-2 receptor activity and when appropriately labeled as probes for the localization of BK-2 receptors in tissue sections. |
| 08/22/2002 | US20020115692 Prophylaxis or treatment of a disease or disorder in a mammal in which inappropriate leukocyte trafficking plays a role |
| 08/22/2002 | US20020115679 N-acyl- or N-sulfonylpiperidine substituted tricyclic benzocycloheptenepyridine derivatives |
| 08/22/2002 | US20020115678 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
| 08/22/2002 | US20020115666 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | US20020115653 Retinoic acid mimetic anilides |
| 08/22/2002 | US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/22/2002 | US20020115640 Such as 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl) methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile; anticancer agents |
| 08/22/2002 | DE10108271A1 Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons Quinoline, isoquinoline and phthalazine derivatives releasing as antagonists of gonadotropin hormone |
| 08/22/2002 | DE10105628A1 Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 08/22/2002 | CA2438712A1 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2436176A1 Thrombin inhibitors |
| 08/22/2002 | CA2436068A1 Thrombin inhibitors |
| 08/22/2002 | CA2434982A1 Pyridine matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1232155A1 Protease inhibitors |
| 08/21/2002 | EP1232154A1 Protease inhibitors |
| 08/21/2002 | EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232147A1 Triazoles as farnesyl transferase inhibitors |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 08/21/2002 | CN1365357A Trifluoromethyl pyri(mi) diene carboxamides |
| 08/21/2002 | CN1365355A Quinoline derivatives as inhibitors of MEK enzymes |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/21/2002 | CN1089337C 1,4-dihydropyridine derivatives |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437138 5-bromo-6-chloro-3-(2-(s)-azetidinyl or pyrrolidinyl-methoxy) pyridine intermediates for the 5-substituted compounds which are potent ligands at neuronal nicotinic cholinergic channel receptors, neurotransmitter controlling agents |
| 08/20/2002 | US6437131 Process for preparing imidazoquinolinamines |
| 08/20/2002 | US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |